U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $114.00 Consensus Price Target from Brokerages

U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus recommendation of “Buy” from the five analysts that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $114.00.

Several research analysts recently issued reports on the company. JMP Securities began coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective for the company. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their target price for the company from $100.00 to $115.00 in a report on Monday, December 16th. Finally, JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $88.49 on Friday. U.S. Physical Therapy has a 12-month low of $76.18 and a 12-month high of $113.63. The stock has a market cap of $1.34 billion, a P/E ratio of 94.14, a PEG ratio of 3.58 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a 50-day moving average of $92.67 and a two-hundred day moving average of $88.92.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy’s payout ratio is 187.23%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Nancy Ham sold 1,172 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now directly owns 1,112 shares of the company’s stock, valued at $107,552.64. The trade was a 51.31 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the sale, the director now owns 16,726 shares of the company’s stock, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,412 shares of company stock worth $706,605 in the last 90 days. 1.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds and other institutional investors have recently modified their holdings of the company. Quest Partners LLC raised its holdings in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after buying an additional 337 shares during the period. Thoroughbred Financial Services LLC acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at $240,000. Oppenheimer Asset Management Inc. boosted its position in U.S. Physical Therapy by 19.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 21,974 shares of the company’s stock worth $2,031,000 after purchasing an additional 3,536 shares during the period. Envestnet Asset Management Inc. increased its holdings in U.S. Physical Therapy by 4.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock valued at $22,179,000 after purchasing an additional 9,434 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in U.S. Physical Therapy by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after purchasing an additional 10,462 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.